Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $1.31 Million - $1.52 Million
11,800 Added 111.32%
22,400 $2.54 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $259,980 - $279,216
2,100 Added 24.71%
10,600 $1.31 Million
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $317,072 - $369,459
-2,800 Reduced 24.78%
8,500 $1.12 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $410,738 - $446,982
4,100 Added 56.94%
11,300 $1.23 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $741,240 - $823,176
7,200 New
7,200 $741,000
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $4.7 Million - $5.28 Million
55,600 Added 102.96%
109,600 $9.44 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $3.67 Million - $4.16 Million
44,000 Added 440.0%
54,000 $4.92 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $51.3 Million - $64.3 Million
-710,000 Reduced 98.61%
10,000 $766,000
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $50.9 Million - $56 Million
710,000 Added 7100.0%
720,000 $54.1 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $66.9 Million - $74 Million
-952,000 Reduced 98.96%
10,000 $778,000
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $40.4 Million - $47.6 Million
587,000 Added 156.53%
962,000 $74.2 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $19 Million - $21.1 Million
265,000 Added 240.91%
375,000 $29.3 Million
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $9.52 Million - $11.2 Million
-165,000 Reduced 60.0%
110,000 $7.7 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $14 Million - $16.3 Million
275,000 New
275,000 $15 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.